Theriva Biologics Inc.

04/18/2026 | Press release | Distributed by Public on 04/18/2026 11:43

Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Theriva Biologics Inc. published this content on April 18, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 18, 2026 at 17:43 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]